Insider Transactions in Q4 2024 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,175
-20.24%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
6,863
-22.4%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,272
-24.81%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
5,556
-22.09%
|
$0
$0.55 P/Share
|
|
Oct 03
2024
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,175
-26.13%
|
$0
$0.55 P/Share
|